Evidence map›Paper›PMID 38684834›Full record

ArticleScientific reports2024

Genotypic analyses of IncHI2 plasmids from enteric bacteria.

Suad Algarni, Dereje D Gudeta, Jing Han, Rajesh Nayak, Steven L Foley

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 21 citations in OpenAlex.

  1. Genomic characterization ofOne health (Amsterdam, Netherlands) · 2026
    Article
  2. Dual resistance to carbapenems and colistin inEmerging microbes & infections · 2026
    Article
  3. Emergence of multidrug resistant Enterobacter spp. in Nigeria: a genomic study.World journal of microbiology & biotechnology · 2026
    Article
  4. Article
  5. Transferable IncHI2-AssociatedFoods (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Emerging Dissemination of blaMicrobiologyOpen · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Complete genome sequence of marineMicrobiology resource announcements · 2026
    Article
  14. Characterization of anAntibiotics (Basel, Switzerland) · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Finding the MissingAntibiotics (Basel, Switzerland) · 2025
    Article
  19. Genomic Analysis of Multidrug ResistantInfection & chemotherapy · 2025
    Article
  20. One Health at Risk: Plasmid-Mediated Spread ofAntibiotics (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Suad AlgarniDivision of Microbiology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Rd, Jefferson, AR, 72079, USA. algarni.so3ad@gmail.com.
Dereje D GudetaDivision of Microbiology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Rd, Jefferson, AR, 72079, USA.
Jing HanDivision of Microbiology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Rd, Jefferson, AR, 72079, USA.
Rajesh NayakOffice of Regulatory Compliance and Risk Management, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Rd, Jefferson, AR, 72079, USA.
Steven L FoleyDivision of Microbiology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Rd, Jefferson, AR, 72079, USA. steven.foley@fda.hhs.gov.
National Center for Toxicological Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Incompatibility (Inc) HI2 plasmids are large (typically > 200 kb), transmissible plasmids that encode antimicrobial resistance (AMR), heavy metal resistance (HMR) and disinfectants/biocide resistance (DBR). To better understand the distribution and diversity of resistance-encoding genes among IncHI2 plasmids, computational approaches were used to evaluate resistance and transfer-associated genes among the plasmids. Complete IncHI2 plasmid (N = 667) sequences were extracted from GenBank and analyzed using AMRFinderPlus, IntegronFinder and Plasmid Transfer Factor database. The most common IncHI2-carrying genera included Enterobacter (N = 209), Escherichia (N = 208), and Salmonella (N = 204). Resistance genes distribution was diverse, with plasmids from Escherichia and Salmonella showing general similarity in comparison to Enterobacter and other taxa, which grouped together. Plasmids from Enterobacter and other taxa had a higher prevalence of multiple mercury resistance genes and arsenic resistance gene, arsC, compared to Escherichia and Salmonella. For sulfonamide resistance, sul1 was more common among Enterobacter and other taxa, compared to sul2 and sul3 for Escherichia and Salmonella. Similar gene diversity trends were also observed for tetracyclines, quinolones, β-lactams, and colistin. Over 99% of plasmids carried at least 25 IncHI2-associated conjugal transfer genes. These findings highlight the diversity and dissemination potential for resistance across different enteric bacteria and value of computational-based approaches for the resistance-gene assessment.

Indexed as

PlasmidsAnti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialEnterobacterEnterobacteriaceaeGenotypeSalmonellaAnti-Bacterial AgentsAntimicrobial resistanceDisinfectant resistanceEnterobacteriaceaeIncHI2 plasmidsMetal resistanceMobile genetic elements

Identifiers

PMID38684834
PMCPMC11058233
OpenAlexW4396242155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.